Forecast & RatingOnly 1 analyst currently covers Novabay Pharmac (NBY.US), with a price target of $4.25 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Feb 23, 2026; this does not constitute investment advice.
Jan 23, 2025Price forecast
$4.25117.95%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateMar 29, 2026
Forecast met29.9%
Stock price$1.95
Avg. target$4.3
High target$4
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.